A study conducted among United States veterans found an increased risk of severe COVID-19 in G6PD-deficient subgroups, particularly among Black veterans under 65 and White veterans aged 65 and older, suggesting that the relationship between G6PDd and disease severity may be modulated by age and ethnicity [20]. Here, G6PD is linked to COVID-19.